Authors:
Lamm, DL
Blumenstein, BA
Crissman, JD
Montie, JE
Gottesman, JE
Lowe, BA
Sarosdy, MF
Bohl, RD
Grossman, HB
Beck, TM
Leimert, JT
Crawford, ED
Citation: Dl. Lamm et al., Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study, J UROL, 163(4), 2000, pp. 1124-1129
Authors:
Piro, LD
White, CA
Grillo-Lopez, AJ
Janakiraman, N
Saven, A
Beck, TM
Varns, C
Shuey, S
Czuczman, M
Lynch, JW
Kolitz, JE
Jain, V
Citation: Ld. Piro et al., Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed orrefractory low-grade or follicular non-Hodgkin's lymphoma, ANN ONCOL, 10(6), 1999, pp. 655-661